Full name
AKADEMICKI OŚRODEK DIAGNOSTYKI PATOMORFOLOGICZNEJ I GENETYCZNO-MOLEKULARNEJ SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
uses securityreCAPTCHA
AKADEMICKI OŚRODEK DIAGNOSTYKI PATOMORFOLOGICZNEJ I GENETYCZNO-MOLEKULARNEJ SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
UL. JERZEGO WASZYNGTONA 13, 15-269 BIAŁYSTOK
TAX ID5423365409
Rate company:
AKADEMICKI OŚRODEK DIAGNOSTYKI PATOMORFOLOGICZNEJ I GENETYCZNO-MOLEKULARNEJ SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
TAX ID5423365409
KRS0000792445
Share capital1,221,000.00 zł
address
UL. JERZEGO WASZYNGTONA 13, 15-269 BIAŁYSTOK
Categories
Main category
Is this your company?Update company information to get new customers, get notified of new reviews, and more!
Register Data
NIP
5423365409
REGON
383731400
KRS
0000792445
Legal form
limited liability company
Register Address
UL. JERZEGO WASZYNGTONA 13, 15-269 BIAŁYSTOK
Date of registration in KRS
2019-06-26
Date of commencement of economic activity
2019-06-26
Act signature
RDF/616104/24/87
Pkd codes
86.90.E - Other human health activities notelsewhere classified
74 - Other professional, scientific and technical activities
77 - Rental and leasing activities
85 - Education
86.1 - Hospital activities
86.2 - Medical and dental practice activities
86.90.A - Physiotherapeutical activities
86.90.C - Nurses and midwives activities
86.90.D - Paramedical activities
96 - Other personal service activities
Payer VAT status
Active
Vat list bank account(s)
PL21 1090 2590 0000 0001 4720 8177 
PL21 1500 1083 1210 8010 9509 0000 PL61 1090 2590 0000 0001 4720 8136 PL80 1090 2590 0000 0001 3655 6224 PL82 1500 1083 1210 8008 4167 0000 PL93 1090 2590 0000 0001 3186 8174 Show more bank accounts from VAT list (3)
Financial data
Net sales [PLN]
Gross profit / loss [PLN]
Automatically generated based on financial statements from KRS Registry
| 2021 | 2022 | 2023 | ||
|---|---|---|---|---|
M PLN | M PLN | M PLN | % | |
Gross profit (loss)  | 7,1 | 0,7 | -1,2 | -261,5 |
EBITDA | 7,7 | 1,5 | -0,4 | -125,2 |
Short time liabilities | 2 | 0,8 | 1 | 25,8 |
Equity capital | 15,8 | 16,4 | 15,3 | -6,9 |
Operating profit (EBIT) | 7,1 | 0,3 | -1,7 | -603,7 |
Assets | 17,9 | 17,2 | 16,7 | -3 |
Net profit (loss) | 5,7 | 0,6 | -1,1 | -287,7 |
Cash | 9,7 | 8,3 | 8,4 | 0,8 |
Net income from sale | 28 | 19,7 | 14,3 | -27,4 |
Liabilities and provisions for liabilities | 2,1 | 0,8 | 1,4 | 73,5 |
Working assets | 13,2 | 12,6 | 12,6 | -0,7 |
Depreciation | 0,6 | 1,1 | 1,3 | 14,4 |
% | % | % | p.p. | |
Profitability of capital | 36,1 | 3,7 | -7,4 | -11,1 |
Equity capital to total assets | 88,5 | 95,2 | 91,5 | -3,7 |
Gross profit margin | 25,2 | 3,8 | -8,5 | -12,3 |
EBITDA Margin | 27,5 | 7,5 | -2,6 | -10,1 |
Days | Days | Days | Days | |
Short term commitment turnover cycle | 26 | 14 | 24 | 10 |
Financial statements
01-01-2023 - 31-12-2023
Annual financial report
Download xml01-01-2023 - 31-12-2023
Annual financial report
Download docx01-01-2023 - 31-12-2023
Activity report
Download pdf01-01-2023 - 31-12-2023
Resolution on profit distribution or loss coverage
Download pdf01-01-2023 - 31-12-2023
Resolution or decision approving the annual financial statements
Download pdfShow more (2)
uses security reCAPTCHA
Opinions
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane
0/ 5.0
How do you rate this company?
Your opinion matters to us.